Ropinirole hydrochloride and Sumatriptan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ropinirole hydrochloride (ropinirole hydrochloride) and Sumatriptan (sumatriptan succinate). Common drug interactions include sinusitis among females and renal failure among males.

The phase IV clinical study analyzes what interactions people have when they take Ropinirole hydrochloride and Sumatriptan. It is created by eHealthMe based on reports of 51 people who take the same drugs from the FDA, and is updated regularly.

What is Ropinirole hydrochloride?

Ropinirole hydrochloride has active ingredients of ropinirole hydrochloride. It is often used in restless leg syndrome. eHealthMe is studying from 4,166 Ropinirole hydrochloride users. Check the latest studies of Ropinirole hydrochloride.

What is Sumatriptan?

Sumatriptan has active ingredients of sumatriptan succinate. It is often used in migraine. eHealthMe is studying from 18,159 Sumatriptan users. Check the latest studies of Sumatriptan.



On Jul, 31, 2026

51 people who take Ropinirole hydrochloride and Sumatriptan together, and have interactions are studied.

Ropinirole hydrochloride and Sumatriptan drug interactions.

What are the common drug interactions of Ropinirole Hydrochloride and Sumatriptan, by gender? *:

female:

  1. Sinusitis (inflammation of sinus)
  2. Headache (pain in head)
  3. Infusion related reaction
  4. Arthralgia (joint pain)
  5. Drug hypersensitivity
  6. Malaise (a feeling of general discomfort or uneasiness)
  7. Colitis (inflammation of colon)
  8. Ear infection
  9. Fatigue (feeling of tiredness)
  10. Nephrolithiasis (calculi in the kidneys)

male:

  1. Renal failure (kidney dysfunction)
  2. Cardiac disorder
  3. Nonspecific reaction (unspecified reaction)
  4. Pneumonia
  5. Adverse drug reaction
  6. Chest pain
  7. Drug ineffective
  8. Dyspepsia (indigestion)
  9. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  10. Blood glucose increased

What are the common drug interactions of Ropinirole Hydrochloride and Sumatriptan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Colitis (inflammation of colon)
  2. Cough
  3. Dizziness
  4. Dry mouth
  5. Dysphagia (a condition in which swallowing is difficult or painful)
  6. Fall
  7. Hallucination (an experience involving the perception of something not present)
  8. Middle insomnia (difficulty returning to sleep after awakening either in the middle of the night)
  9. Muscle twitching
  10. Nausea (feeling of having an urge to vomit)

50-59:

  1. Anaemia (lack of blood)
  2. Blood glucose increased
  3. Decubitus ulcer (a chronic ulcer of the skin caused by prolonged pressure on it)
  4. Dehydration (dryness resulting from the removal of water)
  5. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  6. Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
  7. Dyspnoea (difficult or laboured respiration)
  8. Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
  9. Hepatic steatosis (fatty liver disease)
  10. Hypersensitivity

60+:

  1. Ear infection
  2. Back pain
  3. Swollen tongue (swelling of tongue)
  4. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  5. Influenza
  6. Lymph node pain
  7. Lymphadenopathy (disease or enlargement of lymph nodes)
  8. Pneumonia
  9. Arthralgia (joint pain)
  10. Pain

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 13 people, 25.49%
  2. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 6 people, 11.76%
  3. Pain: 5 people, 9.80%
  4. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 5 people, 9.80%
  5. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 9.80%
  6. High Blood Cholesterol: 4 people, 7.84%
  7. Stress And Anxiety: 3 people, 5.88%
  8. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 5.88%
  9. Neuralgia (pain in one or more nerves): 3 people, 5.88%
  10. Infection: 3 people, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Ropinirole hydrochloride and Sumatriptan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ropinirole hydrochloride and Sumatriptan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ropinirole hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Sumatriptan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ropinirole hydrochloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sumatriptan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ropinirole hydrochloride and sumatriptan succinate (the active ingredients of Ropinirole hydrochloride and Sumatriptan, respectively), and Ropinirole hydrochloride and Sumatriptan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: